# Minimum Effective Dose (MED) & Epidural Bupivacaine

> **NCT02116842** · PHASE4 · UNKNOWN · sponsor: **University of Leeds** · enrollment: 100 (estimated)

## Conditions studied

- Pregnancy
- Labour
- Primigravida Labour
- Epidural Block

## Interventions

- **DRUG:** 0.1% bupivacaine
- **DRUG:** 0.075% bupivacaine
- **DRUG:** 40 µg fentanyl

## Key facts

- **NCT ID:** NCT02116842
- **Lead sponsor:** University of Leeds
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-04-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02116842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02116842, "Minimum Effective Dose (MED) & Epidural Bupivacaine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02116842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*